Clinical Research Directory
Browse clinical research sites, groups, and studies.
Individualized Education for Bortezomib-Related Symptom Management in Multiple Myeloma
Sponsor: Can Lafci
Summary
This study evaluated an individualized, nurse-delivered education program for managing treatment-related symptoms in patients with newly diagnosed multiple myeloma receiving bortezomib for the first time. A total of 40 patients participated. Twenty patients received two individual education sessions in addition to routine care, while 20 patients in the control group received routine care. The education focused on recognition, prevention, and management of common bortezomib-related symptoms, including peripheral neuropathy, pain, nausea, vomiting, diarrhea, constipation, fatigue, anemia, bleeding risk, infection risk, and dyspnea. Treatment-related symptoms were assessed before treatment and education (baseline), on day 21, and on day 63. The study aimed to evaluate whether individualized patient education was associated with differences in the occurrence and severity of treatment-related symptoms over time.
Official title: Investigation of the Effect of Education Given to Patients With Multiple Myeloma on Symptom Severity
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
49
Start Date
2018-02-05
Completion Date
2018-08-31
Last Updated
2026-08-19
Healthy Volunteers
No
Conditions
Interventions
Individualized Nurse-Delivered Education Program
The intervention consisted of two individualized education sessions delivered by the researcher using a Care and Treatment Guide for Patients and Families. The program addressed multiple myeloma and management of bortezomib-related peripheral neuropathy, pain, nausea, vomiting, diarrhea, constipation, fatigue, anemia, bleeding risk, infection risk, and dyspnea. Written and visual materials were used. The second session reinforced topics that were not fully understood, encouraged symptom monitoring with a diary, and provided telephone access to the researcher.
Locations (1)
Ege University Faculty of Medicine, Berna Türek Chemotherapy Center
İzmir, Istanbul, Turkey (Türkiye)